G01N 2333/5409
Il-5
G01N2333/5409 (Il-5) appears on 28 US grants and 64 published applications in this corpus.
Search patents in G01N- Granted patents
- 28
- Published applications
- 64
- Assignees
- 45
- Inventors
- 147
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 3 |
| 2009 | 1 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 3 |
| 2015 | 0 | 4 |
| 2016 | 1 | 1 |
| 2017 | 1 | 6 |
| 2018 | 4 | 1 |
| 2019 | 0 | 5 |
| 2020 | 3 | 3 |
| 2021 | 1 | 5 |
| 2022 | 2 | 8 |
| 2023 | 1 | 5 |
| 2024 | 1 | 5 |
| 2025 | 3 | 5 |
| 2026 | 4 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cytokine-based therapies and methods30 Jun 2026US 12,668,627 B2Reverb Therapeutics, Inc.
- Method of diagnosing overactive bladder disorder26 May 2026US 12,638,459 B2University of Portsmouth Higher Education Corporation
- Method for diagnosing and treating fibromyalgia24 Feb 2026US 12,560,614 B2Center for Immunology Science
- Method for measuring systemic chronic inflammaging6 Jan 2026US 12,517,135 B2Edifice Health, Inc.
- Blood biomarker for eosinophilic gastrointestinal disorders15 Jul 2025US 12,360,103 B2Children's Hospital Medical Center
- Novel cytokine-based therapies and methods17 Sep 2026US 2026/0274943 A1Reverb Therapeutics, Inc.
- Il-5 antibody, antigen binding fragment thereof, and medical application therefor30 Oct 2025US 2025/0333494 A1Jiangsu Hengrui Medicine Co., Ltd.
- System and methods for diagnosing acute interstitial nephritis23 Oct 2025US 2025/0327815 A1
- Novel cytokine-based therapies and methods9 Oct 2025US 2025/0313620 A1Reverb Therapeutics, Inc.
- Novel cytokine-based therapies and methods9 Oct 2025US 2025/0314662 A1Reverb Therapeutics, Inc.
Most cited
By later US patents
- Method for treatment and diagnosis of IL-5 mediated disorders38US 5,783,184 ASmithKline Beecham Corporation · 1998
- EphA2 T-cell epitopes and uses therefor17US 7,297,337 B2MedImmune, LLC · 2007
- EphA2 T-cell epitopes and uses therefor11US 8,114,407 B22012
- Nanoparticle and microparticle based detection of cellular products4US 7,598,093 B2CTL Analyzers, LLC · 2009
- Method for diagnosing fibromyalgia2US 10,018,636 B2Epicgenetics, Inc. · 2018